Epivir-HBV (Lamivudine tablets and oral solution) GlaxoSmithKline

News
Article

New Indication: Hepatitis B indication expanded to pediatric patients

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
olgakris-stock@adobe.com

Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial

Denise Myshko
August 26th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 26th 2025
Podcast

Listen

FDA Approves First in Class Therapy for Hereditary Angioedema

FDA Approves First in Class Therapy for Hereditary Angioedema

Denise Myshko
August 26th 2025
Article

Read More

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar

Logan Lutton
August 26th 2025
Article

Read More

ryanking999-stock.adobe.com

FDA Set Review Date for Imcivree for Rare Form of Obesity

Denise Myshko
August 26th 2025
Article

Read More

Jim Vallee-stock@adobe.com

Medicare Patients Face Higher Drug Costs Despite $2,000 Spending Cap

Denise Myshko
August 26th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.